ATAP Joins PBM Accountability Project to Strengthen Push for Transparency and Reform
Growing Alliance Unites Leading Advocates to Increase Oversight and Protect Patients from Harmful PBM Practices
The Alliance for Transparent & Affordable Prescriptions (ATAP) announced it has formally joined the PBM Accountability Project, a growing coalition dedicated to increasing transparency, oversight, and accountability within the Pharmacy Benefit Manager (PBM) industry.
By joining the PBM Accountability Project, ATAP is deepening its commitment to advancing reforms that prioritize patients, physicians, and employers over opaque middlemen practices that drive up prescription drug costs.
“This partnership represents an important step forward in the fight for accountability within this rogue industry,” said Dr. Robert Levin, President of ATAP. “PBMs have operated in the shadows for far too long, leveraging complex and often hidden business practices that increase costs for patients while limiting access to needed medications. By joining forces with the PBM Accountability Project, we are strengthening a unified voice demanding transparency, fairness, and real reform.”
The PBM Accountability Project brings together a broad range of stakeholders committed to shining a light on PBM practices, including spread pricing, rebate manipulation, and restrictive formularies. ATAP’s provider led perspective adds a critical voice to the coalition, highlighting the real-world impact these practices have on patient care and clinical decision-making.
“ATAP’s decision to join the PBM Accountability Project is a powerful affirmation that frontline physicians and patient advocates are united in demanding real oversight of PBM middlemen,” said Mark Blum, managing director of the PBM Accountability Project. “By combining ATAP’s provider led expertise with our broad coalition of employers, unions, consumer advocates, and pharmacists, we are strengthening a national campaign to end opaque PBM practices, restore transparency to the prescription drug supply chain, and ensure patients- not intermediaries - benefit from the savings their medicines generate.”
“ATAP’s frontline medical professionals see firsthand how PBM-driven barriers can delay treatment, force medication switches, and ultimately harm patients,” Dr. Levin continued. “This alliance amplifies our ability to advocate for policies that restore the doctor-patient relationship and ensure that medical decisions are driven by clinical need, not corporate profit.”
ATAP has been at the forefront of efforts to reform the prescription drug supply chain, advocating for policies that increase competition, eliminate perverse incentives, and require that negotiated savings are passed directly to patients. Through its membership in the PBM Accountability Project, ATAP will collaborate with partners to support legislative and regulatory solutions that bring meaningful oversight to the PBM industry.
“Momentum for PBM reform is building across the country,” Dr. Levin added. “By working together, we can accelerate that progress and deliver the accountability that patients and providers deserve.”
To learn more about ATAP and its mission, visit https://atapadvocates.com. For more information about the PBM Accountability Project, visit https://www.pbmaccountability.org/.
About ATAP
The Alliance for Transparent and Affordable Prescriptions is a physician-led coalition of medical associations and patient advocates working to ensure transparency, fairness, and affordability in the prescription drug supply chain. ATAP is focused on reining in the power of Pharmacy Benefit Managers (PBMs), promoting competition, and restoring the doctor-patient relationship. Through policy advocacy, education, and coalition-building, ATAP is committed to advancing reforms that put patients first and make prescription medications more accessible and affordable for all. Please viisit https://atapadvocates.com and follow @ATAPAdvocates on X.
###
For more information or to schedule an interview with an ATAP spokesperson, please contact Dan Rene at 202-329-8357 or dan@danrene.com.